Ulrich Strych

Ulrich Strych, Ph.D.

(832) 824-0502

strych@bcm.edu

TX Childs Feigin Ctr (Office): Room: TXFC-C1470.34
Houston, TX, 77030
United States
Phone: (832) 824-0502
strych@bcm.edu

McCarty M, Hernández SA, Malfetano J, Leão AC, Villar MJ, Yang X, Chen YL, Lee J, Liu Z, Strych U, Bottazzi ME, Pal U, Strle K, Chen WH, Lin YP.. " " NPJ Vaccines. 2026 ;
Pubmed PMID: .
Hotez PJ, Adhikari R, Chen WH, Chen YL, Gillespie P, Islam NY, Keegan B, Tyagi Kundu R, Lee J, Liu Z, Kimata JT, Oezguen N, Pollet J, Poveda C, Razavi K, Ronca SE, Strych U, Thimmiraju SR, Versteeg L, Villar-Mondragon MJ, Wei J, Zhan B, Bottazzi ME.. " " Expert Review of Vaccines. 2023 ;
Pubmed PMID: .
Bartsch SM, Chin KL, Strych U, John DC, Shah TD, Bottazzi ME, O'Shea KJ, Robertson M, Weatherwax C, Heneghan J, Martinez MF, Ciciriello A, Kulkarni S, Velmurugan K, Dibbs A, Scannell SA, Shen Y, Nash D, Hotez PJ, Lee BY.. " " Journal of Infectious Diseases. 2025 ;
Pubmed PMID: .

: Product Patent #WO 2005020973 A2 (Approved); This invention relates to a group of compounds with anti-mycobacterial activities that have a common hydroxamic acid structural feature and to methods for using same. This invention also relates to compositions including an hydroxamate and an hydroxylamine which possess anti-mycobacterial activity and to methods for making and using same. [0002] More particularly, the present invention relates to compositions capable of inhibiting mycobacterium tuberculosis in standard mycobacterial growth assays, where the compositions include a therapeutically effective amount of an hydroxamate or an therapeutically effective amount of an hydroxamate and an hydroxylamine and to methods for using same.; Co Inventors: Michael Benedik, James M Briggs, Myoung Goo Kim, Harold Kohn, Kurt L Krause

to edit your profile